The prevalence of lung cancer induced by cigarette smoking has increased over time. Long noncoding (lnc) RNAs, regulatory factors that play a role in human diseases, are commonly dysregulated in lung cancer. Cigarette smoking is closely related to changes in lncRNA expression, which can affect lung cancer. Herein, we assess the mechanism of lung cancer initiation induced by smoking. To calculate the impact of smoking on the survival of patients with lung cancer, we extracted data from The Cancer Genome Atlas and Gene Expression Omnibus databases and identified the differentially expressed genes in the lung cancer tissue compared to the normal lung tissue. Genes positively and negatively associated with smoking were identified. Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and Cytoscape analyses were performed to determine the function of the genes and the effects of smoking on the immune microenvironment. lncRNAs corresponding to smoking-associated genes were identified, and a smoking-related lncRNA model was constructed using univariate and multivariate Cox analyses. This model was used to assess the survival of and potential risk in patients who smoked. During screening, 562 differentially expressed genes were identified, and we elucidated that smoking affected the survival of patients 4.5 years after the diagnosis of lung cancer. Furthermore, genes negatively associated with smoking were closely associated with immunity. Twelve immune cell types were also found to infiltrate differentially in smokers and nonsmokers. Thus, the smoking-associated lncRNA model is a good predictor of survival and risk in smokers and may be used as an independent prognostic factor for lung cancer.
This paper considers the periodic self-exciting threshold integer-valued autoregressive processes under a weaker condition in which the second moment is finite instead of the innovation distribution being given. The basic statistical properties of the model are discussed, the quasi-likelihood inference of the parameters is investigated, and the asymptotic behaviors of the estimators are obtained. Threshold estimates based on quasi-likelihood and least squares methods are given. Simulation studies evidence that the quasi-likelihood methods perform well with realistic sample sizes and may be superior to least squares and maximum likelihood methods. The practical application of the processes is illustrated by a time series dataset concerning the monthly counts of claimants collecting short-term disability benefits from the Workers’ Compensation Board (WCB). In addition, the forecasting problem of this dataset is addressed.
Chronic diseases, particularly those with progressive neurological impairment, present a significant challenge in healthcare due to their impact on millions globally and the limited availability of effective therapies. Addressing this challenge requires innovative approaches, such as leveraging individuals’ genetic features for early intervention and treatment strategies. Due to the irregular intervals of patient visits, clinical data typically appear as censored, necessitating advanced analytical methods. Thus, this study introduces GTsurvival, a novel network architecture that combines graph convolutional networks (GCN) with a neural decision tree, providing promising advancements in disease prediction. GTsurvival utilizes restricted mean survival time (RMST) as pseudo-observations and directly connects them with baseline variables. Through the joint simulation of RMST, GTsurvival can effectively utilize shared information and enhance its predictive ability for patients’ future survival status. Firstly, GTsurvival is introduced to handle complex censored data, emphasizing the crucial role of graphs utilized in GCNs for processing related information among samples. Secondly, the neural decision tree within GTsurvival enhances decision-making by mitigating uncertainty at split nodes, effectively minimizing the global loss function and optimizing survival analysis in high-dimensional datasets. Thirdly, evaluations on simulated datasets and a real-world neurodegenerative disease cohort verify that the proposed GTsurvival method surpasses existing approaches. This superiority is partly attributed to the inclusion of a generalized score test during feature selection, which helps capture variants associated with disease progression.
GARCH models play a fundamental role in modeling time-varying volatility in financial return series. In practice, financial returns are also well known to exhibit heavy-tailed distributions, which naturally motivates the use of quasi-maximum exponential likelihood estimation (QMELE) for accurately capturing tail behavior and risk measures such as Value-at-Risk. At the same time, the increasing availability of intraday high-frequency data has led to the development of high-frequency augmented GARCH models, which incorporate intraday information into conventional low-frequency volatility frameworks. By exploiting transaction-level data recorded at very fine time scales, these models are able to capture intraday volatility dynamics and market microstructure effects that are not reflected in standard low-frequency observations. Against this background, this paper studies conditional quantile estimation for high-frequency augmented GARCH models. We develop QMELE-based estimators for both model parameters and conditional quantiles, and construct an adjusted test statistic for assessing model adequacy. The asymptotic properties of the proposed estimators and test statistic are established, and their finite-sample performance is examined through extensive simulation studies. Empirical applications to three major stock indices demonstrate that augmenting GARCH models with high-frequency information leads to substantial improvements in conditional quantile estimation compared with traditional low-frequency approaches.